Company Filing History:
Years Active: 2013-2019
Title: The Innovations of Leong Loke Ng
Leong Loke Ng is a notable inventor based in Leicester, GB, recognized for his significant contributions to medical diagnostics. With a commendable portfolio of 6 patents, he has made remarkable strides in improving the understanding and detection of critical health conditions like myocardial infarction.
Latest Patents
Among his latest innovations are two impactful patents relating to the diagnosis of acute coronary syndrome (ACS). The first patent presents an in vitro method for the early or differential diagnosis and prognosis of myocardial infarction in patients. This invention focuses on risk stratification for acute coronary syndrome by measuring provasopressin (proAVP) or its fragments, particularly copeptin or neurophysin II. The second patent elaborates methods for the in vitro diagnosis of ACS, myocardial infarction, or angina pectoris through the determination of neurophysin II levels in patient samples. Both patents highlight his commitment to advancing medical diagnostic techniques.
Career Highlights
Leong Loke Ng currently works at B.R.A.H.M.S GmbH, a company dedicated to innovation in diagnostics and laboratory services. His role in the company has enabled him to explore and develop vital technologies that assist in early detection of serious health issues.
Collaborations
Throughout his career, Leong has collaborated with esteemed colleagues like Andreas Bergmann and Joachim Struck. These partnerships have further facilitated the development of innovative diagnostic solutions, showcasing the importance of teamwork in the field of medical research and invention.
Conclusion
Leong Loke Ng's dedication to innovation in medical diagnostics, exemplified through his patents and collaborations, positions him as a significant figure in contemporary healthcare technology. His contributions not only enhance diagnostic methodologies but also play a crucial role in improving patient care and outcomes.